| HER2-Positive Breast Cancer | BRCA | Trastuzumab | PD-1 | PDCD1 | clinical trail | 26842237 | Details |  |  |  |  |
| HER2-Positive Breast Cancer | BRCA | Ad5/3-Δ24-tras | CD11c+ DCs | CD16+ dendritic cell | mouse model | 27458139 | Details | | | | |
| HER2-Positive Breast Cancer | BRCA | Ad5/3-Δ24-tras | CD11c+ DCs | Conventional dendritic cell | mouse model | 27458139 | Details | | | | |
| HER2-Positive Breast Cancer | BRCA | Ad5/3-Δ24-tras | CD11c+ DCs | Myeloid conventional dendritic cell | mouse model | 27458139 | Details | | | | |
| HER2-Positive Breast Cancer | BRCA | Ad5/3-Δ24-tras | CD11c+ DCs | Dendritic cell | mouse model | 27458139 | Details | | | | |
| HER2-Positive Breast Cancer | BRCA | Ad5/3-Δ24-tras | CD11c+ DCs | Plasmacytoid dendritic cell | mouse model | 27458139 | Details | | | | |
| HER2-Positive Breast Cancer | BRCA | Ad5/3-Δ24-tras | CD11c+ DCs | Monocyte derived dendritic cell | mouse model | 27458139 | Details | | | | |
| HER2-Positive Breast Cancer | BRCA | Ad5/3-Δ24-tras | CD11c+ DCs | Myeloid dendritic cell | mouse model | 27458139 | Details | | | | |
| HER2-Positive Breast Cancer | BRCA | Ad5/3-Δ24-tras | CD11c+ CD80+ CD40+ cells | B cell | mouse model | 27458139 | Details | | | | |
| HER2-Positive Breast Cancer | BRCA | Ad5/3-Δ24-tras | CD11c+ CD80+ CD40+ cells | Myeloid cell | mouse model | 27458139 | Details | | | | |
| HER2-Positive Breast Cancer | BRCA | Ad5/3-Δ24-tras | CD11c+ CD80+ CD40+ cells | Myeloid dendritic cell | mouse model | 27458139 | Details | | | | |
| HER2-Positive Breast Cancer | BRCA | Ad5/3-Δ24-tras | CD11c+ CD80+ CD40+ cells | Plasmacytoid dendritic cell | mouse model | 27458139 | Details | | | | |
| HER2-Positive Breast Cancer | BRCA | Ad5/3-Δ24-tras | CD11c+ CD80+ CD40+ cells | Specialist antigen presenting cell | mouse model | 27458139 | Details | | | | |